Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
Context Owing to the complexity of chemical ingredients in traditional Chinese medicine (TCM), it is difficult to maintain quality and efficacy by relying only on chemical markers. Objective Lianhua Qingwen capsule (LHQW) was selected as an example to discuss the feasibility of a bioassay for qualit...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13880209.2021.1917627 |
id |
doaj-b591df432d1e4bf0ac77902b07c6dfd1 |
---|---|
record_format |
Article |
spelling |
doaj-b591df432d1e4bf0ac77902b07c6dfd12021-05-06T15:44:48ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162021-01-0159153754510.1080/13880209.2021.19176271917627Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)Shuaishuai Chen0Xiaojuan Yang1Ziying Wei2Yanru Zhang3Ying Huang4Zhuo Shi5Ziteng Zhang6Jiabo Wang7Haizhu Zhang8Jianli Ma9Xiaohe Xiao10Ming Niu11School of Pharmacy, Chengdu University of Traditional Chinese MedicineChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalCollege of Pharmacy and Chemistry, Dali UniversityDepartment of Pharmacy, The Fourth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalDepartment of Hematology, The Fifth Medical Center of Chinese, PLA General HospitalContext Owing to the complexity of chemical ingredients in traditional Chinese medicine (TCM), it is difficult to maintain quality and efficacy by relying only on chemical markers. Objective Lianhua Qingwen capsule (LHQW) was selected as an example to discuss the feasibility of a bioassay for quality control. Materials and methods Network pharmacology was used to screen potential targets in LHQW with respect to its anti-inflammatory effects. An in vitro cell model was used to validate the prediction. An anti-inflammatory bioassay was established for the quality evaluation of LHQW in 40 batches of marketed products and three batches of destructed samples. Results The tumor necrosis factor/interleukin-6 (TNF/IL-6) pathway via macrophage was selected as the potential target of LHQW. The IC50 value of LHQW on RAW 264.7 was 799.8 μg/mL. LHQW had significant inhibitory effects on the expression of IL-6 in a dose-dependent manner (p < 0.05). The anti-inflammatory biopotency of LHQW was calculated based on the inhibitory bioactivity on IL-6. The biopotency of 40 marketed samples ranged from 404 U/μg to 2171 U/μg, with a coefficient of variation (CV) of 37.91%. By contrast, the contents of forsythin indicated lower CV (28.05%) than the value of biopotency. Moreover, the biopotencies of destructed samples declined approximate 50%, while the contents of forsythin did not change. This newly established bioassay revealed a better ability to discriminate the quality variations of LHQW as compared to the routine chemical determination. Conclusions A well-established bioassay may have promising ability to reveal the variance in quality of TCM.http://dx.doi.org/10.1080/13880209.2021.1917627biopotencymacrophagenetwork pharmacologyquality variationinterleukin-6 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shuaishuai Chen Xiaojuan Yang Ziying Wei Yanru Zhang Ying Huang Zhuo Shi Ziteng Zhang Jiabo Wang Haizhu Zhang Jianli Ma Xiaohe Xiao Ming Niu |
spellingShingle |
Shuaishuai Chen Xiaojuan Yang Ziying Wei Yanru Zhang Ying Huang Zhuo Shi Ziteng Zhang Jiabo Wang Haizhu Zhang Jianli Ma Xiaohe Xiao Ming Niu Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen) Pharmaceutical Biology biopotency macrophage network pharmacology quality variation interleukin-6 |
author_facet |
Shuaishuai Chen Xiaojuan Yang Ziying Wei Yanru Zhang Ying Huang Zhuo Shi Ziteng Zhang Jiabo Wang Haizhu Zhang Jianli Ma Xiaohe Xiao Ming Niu |
author_sort |
Shuaishuai Chen |
title |
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen) |
title_short |
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen) |
title_full |
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen) |
title_fullStr |
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen) |
title_full_unstemmed |
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen) |
title_sort |
establishment of an anti-inflammation-based bioassay for the quality control of the 13-component tcm formula (lianhua qingwen) |
publisher |
Taylor & Francis Group |
series |
Pharmaceutical Biology |
issn |
1388-0209 1744-5116 |
publishDate |
2021-01-01 |
description |
Context Owing to the complexity of chemical ingredients in traditional Chinese medicine (TCM), it is difficult to maintain quality and efficacy by relying only on chemical markers. Objective Lianhua Qingwen capsule (LHQW) was selected as an example to discuss the feasibility of a bioassay for quality control. Materials and methods Network pharmacology was used to screen potential targets in LHQW with respect to its anti-inflammatory effects. An in vitro cell model was used to validate the prediction. An anti-inflammatory bioassay was established for the quality evaluation of LHQW in 40 batches of marketed products and three batches of destructed samples. Results The tumor necrosis factor/interleukin-6 (TNF/IL-6) pathway via macrophage was selected as the potential target of LHQW. The IC50 value of LHQW on RAW 264.7 was 799.8 μg/mL. LHQW had significant inhibitory effects on the expression of IL-6 in a dose-dependent manner (p < 0.05). The anti-inflammatory biopotency of LHQW was calculated based on the inhibitory bioactivity on IL-6. The biopotency of 40 marketed samples ranged from 404 U/μg to 2171 U/μg, with a coefficient of variation (CV) of 37.91%. By contrast, the contents of forsythin indicated lower CV (28.05%) than the value of biopotency. Moreover, the biopotencies of destructed samples declined approximate 50%, while the contents of forsythin did not change. This newly established bioassay revealed a better ability to discriminate the quality variations of LHQW as compared to the routine chemical determination. Conclusions A well-established bioassay may have promising ability to reveal the variance in quality of TCM. |
topic |
biopotency macrophage network pharmacology quality variation interleukin-6 |
url |
http://dx.doi.org/10.1080/13880209.2021.1917627 |
work_keys_str_mv |
AT shuaishuaichen establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT xiaojuanyang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT ziyingwei establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT yanruzhang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT yinghuang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT zhuoshi establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT zitengzhang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT jiabowang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT haizhuzhang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT jianlima establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT xiaohexiao establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen AT mingniu establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen |
_version_ |
1721456527570632704 |